289 related articles for article (PubMed ID: 30088345)
1. Three-step algorithm for biological therapy targeted IgE and IL-5 in severe asthma.
Oishi K; Matsunaga K
Immun Inflamm Dis; 2018 Sep; 6(3):374-376. PubMed ID: 30088345
[TBL] [Abstract][Full Text] [Related]
2. A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma.
Oishi K; Hirano T; Suetake R; Ohata S; Yamaji Y; Ito K; Edakuni N; Matsunaga K
Immun Inflamm Dis; 2017 Sep; 5(3):261-264. PubMed ID: 28474411
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.
Dimitrova D; Youroukova V; Ivanova-Todorova E; Tumangelova-Yuzeir K; Velikova T
Respir Med; 2019; 154():144-154. PubMed ID: 31260861
[TBL] [Abstract][Full Text] [Related]
4. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
Nagase H; Ueki S; Fujieda S
Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
[TBL] [Abstract][Full Text] [Related]
5. Value of Exhaled Nitric Oxide (FeNO) And Eosinophilia During the Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospital Admission.
Río Ramírez MT; Juretschke Moragues MA; Fernández González R; Álvarez Rodríguez V; Aznar Andrés E; Zabaleta Camino JP; Romero Pareja R; Esteban de la Torre A
COPD; 2018; 15(4):369-376. PubMed ID: 30064275
[TBL] [Abstract][Full Text] [Related]
6. IgE and eosinophils as therapeutic targets in asthma.
Patel TR; Sur S
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):42-49. PubMed ID: 27906698
[TBL] [Abstract][Full Text] [Related]
7. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
Matucci A; Vultaggio A; Maggi E; Kasujee I
Respir Res; 2018 Jun; 19(1):113. PubMed ID: 29879991
[TBL] [Abstract][Full Text] [Related]
8. Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.
Kambara R; Minami T; Akazawa H; Tsuji F; Sasaki T; Inohara H; Horii A
Int Arch Allergy Immunol; 2017; 173(4):225-232. PubMed ID: 28848094
[TBL] [Abstract][Full Text] [Related]
9. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.
Crespo A; Giner J; Torrejón M; Belda A; Mateus E; Granel C; Torrego A; Ramos-Barbón D; Plaza V
J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727
[TBL] [Abstract][Full Text] [Related]
10. Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective.
Caminati M; Vianello A; Chieco Bianchi F; Festi G; Guarnieri G; Marchi MR; Micheletto C; Olivieri M; Tognella S; Guerriero M; Senna G;
J Investig Allergol Clin Immunol; 2020; 30(1):35-41. PubMed ID: 30676321
[TBL] [Abstract][Full Text] [Related]
11. Smoking attenuates the age-related decrease in IgE levels and maintains eosinophilic inflammation.
Nagasaki T; Matsumoto H; Nakaji H; Niimi A; Ito I; Oguma T; Muro S; Inoue H; Iwata T; Tajiri T; Kanemitsu Y; Mishima M
Clin Exp Allergy; 2013 Jun; 43(6):608-15. PubMed ID: 23711122
[TBL] [Abstract][Full Text] [Related]
12. Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.
Esnault S; Kelly EA
Crit Rev Immunol; 2016; 36(5):429-444. PubMed ID: 28605348
[TBL] [Abstract][Full Text] [Related]
13. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
[TBL] [Abstract][Full Text] [Related]
14. Improving the diagnosis of eosinophilic asthma.
Coumou H; Bel EH
Expert Rev Respir Med; 2016 Oct; 10(10):1093-103. PubMed ID: 27624868
[TBL] [Abstract][Full Text] [Related]
15. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
16. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
[TBL] [Abstract][Full Text] [Related]
17. The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.
Kupryś-Lipińska I; Molińska K; Kuna P
Pneumonol Alergol Pol; 2016; 84(4):232-43. PubMed ID: 27435350
[TBL] [Abstract][Full Text] [Related]
18. Determinants of exhaled nitric oxide levels (FeNO) in childhood atopic asthma: evidence for neonatal respiratory distress as a factor associated with low FeNO levels.
Ricciardolo FL; Silvestri M; Pistorio A; Strozzi MM; Tosca MA; Bellodi SC; Battistini E; Gardella C; Rossi GA
J Asthma; 2010 Sep; 47(7):810-6. PubMed ID: 20626311
[TBL] [Abstract][Full Text] [Related]
19. Aeroallergen and food IgE sensitization and local and systemic inflammation in asthma.
Patelis A; Janson C; Borres MP; Nordvall L; Alving K; Malinovschi A
Allergy; 2014 Mar; 69(3):380-7. PubMed ID: 24397423
[TBL] [Abstract][Full Text] [Related]
20. A pathophysiological approach for FeNO: A biomarker for asthma.
Ricciardolo FL; Sorbello V; Ciprandi G
Allergol Immunopathol (Madr); 2015; 43(6):609-16. PubMed ID: 25796309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
